Neil S. Horowitz

43.6k total citations
214 papers, 4.9k citations indexed

About

Neil S. Horowitz is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Neil S. Horowitz has authored 214 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Reproductive Medicine, 89 papers in Public Health, Environmental and Occupational Health and 66 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Neil S. Horowitz's work include Ovarian cancer diagnosis and treatment (91 papers), Gestational Trophoblastic Disease Studies (75 papers) and Prenatal Screening and Diagnostics (56 papers). Neil S. Horowitz is often cited by papers focused on Ovarian cancer diagnosis and treatment (91 papers), Gestational Trophoblastic Disease Studies (75 papers) and Prenatal Screening and Diagnostics (56 papers). Neil S. Horowitz collaborates with scholars based in United States, Brazil and United Kingdom. Neil S. Horowitz's co-authors include Ross S. Berkowitz, Ursula A. Matulonis, Donald P. Goldstein, Kevin M. Elias, Susana M. Campos, Brooke E. Howitt, Carolyn Krasner, Richard T. Penson, Marcela G. del Carmen and Noah Rodriguez and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Neil S. Horowitz

199 papers receiving 4.8k citations

Peers

Neil S. Horowitz
Jubilee Brown United States
Linda Duska United States
Serge Uzan France
John T. Soper United States
Ritu Salani United States
Heinz Koelbl Germany
Jubilee Brown United States
Neil S. Horowitz
Citations per year, relative to Neil S. Horowitz Neil S. Horowitz (= 1×) peers Jubilee Brown

Countries citing papers authored by Neil S. Horowitz

Since Specialization
Citations

This map shows the geographic impact of Neil S. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil S. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil S. Horowitz more than expected).

Fields of papers citing papers by Neil S. Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil S. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil S. Horowitz. The network helps show where Neil S. Horowitz may publish in the future.

Co-authorship network of co-authors of Neil S. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Neil S. Horowitz. A scholar is included among the top collaborators of Neil S. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil S. Horowitz. Neil S. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braga, Antônio, Solange Artimos de Oliveira, José Mauro Madi, et al.. (2025). Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors. Clinics. 80. 100583–100583. 1 indexed citations
2.
Konstantinopoulos, Panagiotis A., Elizabeth K. Lee, Carolyn Krasner, et al.. (2025). Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer. JCO Precision Oncology. 9(9). e2400882–e2400882.
3.
Braga, Antônio, et al.. (2024). Treatment of High-Risk Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. 38(6). 1245–1258. 2 indexed citations
4.
Elias, Kevin M., Ross S. Berkowitz, & Neil S. Horowitz. (2024). Surgical Management of Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. 38(6). 1287–1295. 2 indexed citations
5.
Elias, Kevin M., Ross S. Berkowitz, & Neil S. Horowitz. (2024). Ultra High-risk Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. 38(6). 1259–1264.
6.
Wang, Victoria, Kevin M. Elias, Ross S. Berkowitz, & Neil S. Horowitz. (2024). Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors. Hematology/Oncology Clinics of North America. 38(6). 1277–1286. 2 indexed citations
7.
Braga, Antônio, et al.. (2024). Diagnosis and Management of Molar Pregnancies. Hematology/Oncology Clinics of North America. 38(6). 1149–1159. 4 indexed citations
8.
Maestá, Izildinha, Roberto Costa, Antônio Braga, et al.. (2023). Geographical Health District and Distance Traveled Influence on Clinical Status at Admission of Patients with Gestational Trophoblastic Disease. Revista Brasileira Ginecologia e Obstetrícia. 45(7). e384–e392.
9.
Braga, Antônio, José Mauro Madi, Kevin M. Elias, et al.. (2023). Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases. Clinics. 78. 100260–100260. 13 indexed citations
10.
Campos, Susana M., Suzanne Berlin, Carolyn Krasner, et al.. (2022). A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies. Cancer Chemotherapy and Pharmacology. 89(3). 423–430. 4 indexed citations
11.
Yoon, Ju‐Yoon, David B. Chapel, Xiaohua Qian, et al.. (2022). Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention. The Journal of Pathology. 257(3). 255–261. 6 indexed citations
12.
Trivedi, Meghna S., Nadir Arber, Eitan Friedman, et al.. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research. 15(11). 721–726. 3 indexed citations
13.
Maestá, Izildinha, María Inés Bianconi, Kevin M. Elias, et al.. (2022). Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia. Revista Brasileira Ginecologia e Obstetrícia. 44(8). 746–754. 1 indexed citations
14.
Gockley, Allison, Lawrence Hsu Lin, Michelle Davis, et al.. (2021). Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy. Clinics. 76. e2830–e2830. 5 indexed citations
15.
Braga, Antônio, Kevin M. Elias, Neil S. Horowitz, & Ross S. Berkowitz. (2021). Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia. Revista Brasileira Ginecologia e Obstetrícia. 43(7). 503–506. 1 indexed citations
16.
Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2021). Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. Journal of Clinical Oncology. 39(14). 1531–1539. 115 indexed citations
17.
Braga, Antônio, et al.. (2020). Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. Clinics. 75. e1724–e1724. 7 indexed citations
18.
Sun, Sue Yazaki, et al.. (2018). Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. Journal of Medical Internet Research. 20(9). e10897–e10897. 15 indexed citations
19.
Watkins, Jaclyn C., Eric Yang, Michael G. Muto, et al.. (2016). Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. International Journal of Gynecological Pathology. 36(2). 115–127. 67 indexed citations
20.
Gius, David, Eric Y. Chuang, Sheng Feng, et al.. (2007). Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates. Cancer Research. 67(15). 7113–7123. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026